Rabies vaccine + Japanese encephalitis vaccine

A combination regimen of rabies vaccine and Japanese encephalitis (JE) vaccine is used for pre-exposure prophylaxis in individuals at risk for both diseases, particularly travelers to endemic regions. Both vaccines are administered to induce protective immunity against their respective viruses. The rabies vaccine is typically a purified cell culture or embryonated egg-based inactivated virus preparation, while the JE vaccine is most commonly an inactivated, adsorbed formulation such as Ixiaro. Mechanistically, both vaccines work by stimulating the immune system to produce neutralizing antibodies specific to each virus, thereby providing protection against infection. Clinical studies have demonstrated that concomitant administration of these vaccines—either on standard or accelerated schedules—results in strong immunogenicity and safety profiles comparable to when each is given alone[1][2][3]. This approach allows for rapid immunization when time before potential exposure is limited.

Brand names

IxiaroRabipurImovax Rabies

Other names

JE vaccineinactivated Vero cell-derived Japanese encephalitis vaccinepurified chick embryo cell culture rabies vaccine